大幅跑赢市场！十大核心ETF上半年业绩出炉，港股创新药ETF领涨，A500ETF基金(512050)收红

Market Performance - The A-share market saw all major indices rise in the first half of the year, with the Shanghai Composite Index increasing by 2.76%, the North Star 50 Index soaring by 39.45%, and the Wind Micro Index achieving a historical high with a gain of over 43% [1] - Over 3,700 stocks in the market rose, with more than 100 stocks increasing by over 100% [1] Sector Highlights - Various sectors attracted significant capital, including AI large models, humanoid robots, new consumption, innovative drugs, and solid-state batteries [1] - Nearly 20 bank stocks reached historical highs in the first half of the year [1] ETF Performance - The top ten core ETFs in the "Global Vision, Betting on China" category rose by 10.21%, significantly outperforming the CSI 300 Index, which only increased by 0.03% [3] - The Hong Kong Innovation Drug ETF led the performance with a remarkable increase of 56.69% [6] - The A500 ETF Fund (512050) recorded a gain of 1.47% in the first half of the year [3][5] Industry Insights - The A500 Index employs an industry-balanced sampling method, covering 35 sub-industries, with industrials (22.1%) and information technology (19.1%) as the top two sectors [5] - The index's net asset return on equity (ROE) has maintained around 9%, with a projected profit growth rate of 11.6% for 2025 [5] - The Hong Kong innovative drug sector's competitiveness has strengthened, with international revenue significantly improving the profit structure of pharmaceutical companies [8] Brokerage Sector - The brokerage ETF fell by 3% in the first half of the year, despite a strong performance from leading brokerages, which saw net profit growth exceeding 50% in Q1 2025 [9][11] - The average daily trading volume in A-shares remained above 1 trillion yuan, supporting brokerage revenue growth [11] - The brokerage sector is expected to benefit from ongoing capital market reforms and a stable trading environment in the second half of the year [11]